Kingfisher Capital LLC Gilead Sciences, Inc. Transaction History

Kingfisher Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $1.29 Million - $1.62 Million	-20,744 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $185,841 - $215,796	2,569 Added 14.13%	20,744 $1.6 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $1.14 Million - $1.46 Million	18,175 New	18,175 $1.36 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $202,253 - $226,803	-3,269 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1,875 - $2,101	30 Added 0.93%	3,269 $213,000
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $7,688 - $10,033	127 Added 4.08%	3,239 $203,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $18,675 - $20,677	-262 Reduced 7.77%	3,112 $240,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $21,605 - $25,201	333 Added 10.95%	3,374 $239,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $2,063 - $2,422	-29 Reduced 0.94%	3,041 $218,000
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $5,047 - $5,982	70 Added 2.33%	3,070 $249,000
Q2 2017 Aug 15, 2017	BUY	N/A	3,000	3,000 $212,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kingfisher Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Kingfisher Capital LLC with notifications on news.